Semaglutide for Smoking Cessation in Patients With Diabetes

NCT07059377 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Nicotine Addiction
Tobacco Dependence

Interventions

DRUG: Semaglutide
DRUG: Nicotine replacement

Sponsor

Ottawa Heart Institute Research Corporation